Adjuvo is pleased to announce its investment in NoBACZ Healthcare, a Cambridge-based spinout developing a patented antibiotic-free liquid bandage for livestock and horses. The company has successfully raised £4.8 million in a funding round alongside Yield Lab, with participation from ACF Investors, Parkwalk Advisors, The FSE Group, and Cambridge Enterprise Ventures.

NoBACZ Healthcare’s innovative liquid bandage is waterproof, biodegradable, and antibiotic-free, providing effective wound protection while improving animal welfare and reducing reliance on antibiotics. The solution is already making a tangible impact in veterinary care, and the team is preparing to scale internationally while exploring potential applications in human healthcare.

“For too long, topical antibiotics and bandages have offered inadequate solutions for animal wound care. NoBACZ’s patented platform technology sets a new benchmark, delivering ground-breaking results while aligning with Adjuvo's mission to back innovation in underserved sectors. Led by globally recognised experts from the University of Cambridge, we are proud to support the team as they transform wound management in livestock and beyond.”

This funding round highlights the growing demand for sustainable, antibiotic-free veterinary solutions and reinforces Cambridge’s position as a hub for life sciences and veterinary innovation.
 

You can read more about this investment in the full article published by Sky News here.